The British Columbia Athletic Commission on Thursday revealed that Ali Bagautinov tested positive for erythropoietin (EPO) during a random drug test prior to his UFC 174 challenge of flyweight champion Demetrious Johnson . Due to the processing time at the laboratory, the results of the June 2 drug test weren’t known until after Bagautinov had already lost a five-round unanimous decision to Johnson on June 14 in Vancouver. The BCAC revoked Bagautinov’s license and suspended him for one year . The Ultimate Fighting Championship on Thursday threw its full support behind the BCAC’s decision, adding that Bagautinov must pass a drug test before he can gain clearance to ever fight in the UFC again. The UFC statement on Ali Bagautinov: “UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO).
Originally posted here:
UFC Releases Statement on Ali Bagautinov Testing Positive for EPO – MMA Weekly